An American Society of Health-System Pharmacists and the University of Utah report finds that the number of active drug shortages is 277, down from an all-time high of 323.
Ivabradine is indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction.